Colchicine

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Colchicine is an anti-inflammatory that also acts as an immunomodulator and is used for a number of different illnesses including gout, recurrent pericarditis, and familial Mediterranean fever.[1][2][3] Colchicine is also sold under the brand names Colcrys, Mitigare, Gloperba.[3]

Theory[edit | edit source]

Evidence[edit | edit source]

Clinicians[edit | edit source]

Risks and safety[edit | edit source]

Costs and availability[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. ↑ "Colchicine | COVID-19 Treatment Guidelines". National Institutes of Health. Retrieved January 3, 2022.
  2. ↑ "Colchicine". drugs.com. Retrieved January 3, 2022.
  3. ↑ 3.0 3.1 "Colchicine: MedlinePlus Drug Information". MedlinePlus. Retrieved January 3, 2022.

immunomodulator An immunomodulator is a substance that affects the functioning of the immune system

National Institutes of Health (NIH) - A set of biomedical research institutes operated by the U.S. government, under the auspices of the Department of Health and Human Services.

Retrieved from "https://me-pedia.org/w/index.php?title=Colchicine&oldid=237484"